<table-wrap xmlns:ali="http://www.niso.org/schemas/ali/1.0/" xmlns:xlink="http://www.w3.org/1999/xlink" id="inlinetable1" position="anchor"><table frame="hsides" rules="groups"><thead><tr><th>Plasmid name</th><th>Purpose</th><th>Brief description</th><th>Backbone vector</th><th>Promoter</th></tr></thead><tbody><tr><td valign="bottom">pRSET-Nanobody-3xFLAG-His</td><td valign="bottom">bacterial expression</td><td valign="bottom">3xFLAG-tagged anti-GFP <break/>nanobody</td><td valign="bottom">pRSET</td><td valign="bottom">T7</td></tr><tr><td valign="bottom">pX330-TMED10 sgRNA2</td><td valign="bottom">mammalian cell expression</td><td valign="bottom">sgRNA targeting <break/>TMED10 <break/>(TAACGGAAAAGGGCCGCGCC)</td><td valign="bottom">pX330 (&#916;Cas9)</td><td valign="bottom">U6</td></tr><tr><td valign="bottom">pX330-TMED10 sgRNA3</td><td valign="bottom">mammalian cell expression</td><td valign="bottom">sgRNA targeting <break/>TMED10 <break/>(GCAGCAACGCTAACGGAAAA)</td><td valign="bottom">pX330 (&#916;Cas9)</td><td valign="bottom">U6</td></tr><tr><td valign="bottom">pcDNA3-HA-TMED10</td><td valign="bottom">mammalian cell expression</td><td valign="bottom">Human TMED10 with HA tag <break/>following signal sequence</td><td valign="bottom">pcDNA3.1 (+) zeo</td><td valign="bottom">CMV</td></tr><tr><td valign="bottom">pcDNA3-HA-TMED10 si2R</td><td valign="bottom">mammalian cell expression</td><td valign="bottom">HA-tagged human TMED10 <break/>as above with silent <break/>mutations to confer <break/>resistance to Stealth <break/>RNAi TMED10HSS145904</td><td valign="bottom">pcDNA3.1 (+) zeo</td><td valign="bottom">CMV</td></tr><tr><td valign="bottom">pcDNA3-HA-RFP-TMED10</td><td valign="bottom">mammalian cell expression</td><td valign="bottom">Human TMED10 with HA <break/>tag and RFP following <break/>signal sequence</td><td valign="bottom">pcDNA3.1 (+) zeo</td><td valign="bottom">CMV</td></tr><tr><td valign="bottom">pcDNA3-HA-TMED10 &#916;CC</td><td valign="bottom">mammalian cell expression</td><td valign="bottom">Human TMED10 lacking <break/>coiled-coil domain (amino <break/>acids 130&#8211;183); HA-tagged</td><td valign="bottom">pcDNA3.1 (+) zeo</td><td valign="bottom">CMV</td></tr><tr><td valign="bottom">pcDNA3-HA-RFP-TMED10 &#916;GOLD</td><td valign="bottom">mammalian cell expression</td><td valign="bottom">GOLD domain deleted <break/>(residues 41&#8211;129 of original <break/>protein); HA- and RFP-tagged</td><td valign="bottom">pcDNA3.1 (+) zeo</td><td valign="bottom">CMV</td></tr><tr><td valign="bottom">pcDNA3-HA-RFP-TMED10 &#916;CC</td><td valign="bottom">mammalian cell expression</td><td valign="bottom">Human TMED10 lacking <break/>coiled-coil domain <break/>(amino acids 130&#8211;183); <break/>HA- and RFP-tagged</td><td valign="bottom">pcDNA3.1 (+) zeo</td><td valign="bottom">CMV</td></tr><tr><td valign="bottom">FKBP*12(F36V/L106P)-YFP-GPI</td><td valign="bottom">mammalian cell expression</td><td valign="bottom">FKBP*12 containing <break/>destabilizing mutations, <break/>followed by YFP and GPI- <break/>anchor signal. For transient <break/>expression.</td><td colspan="2" valign="bottom">Derived from FKBP12-YFP-GPI <break/>(<xref ref-type="bibr" rid="bib38">Sengupta et al., 2015</xref>) provided by <break/>J. Lippincott-Schwartz</td></tr><tr><td valign="bottom">FKBP*12(F36V/L106P)-BFP</td><td valign="bottom">mammalian cell expression</td><td valign="bottom">FKBP*12 containing <break/>destabilizing mutations, <break/>followed by BFP</td><td valign="bottom">pcDNA3.1 (+) zeo</td><td valign="bottom">CMV</td></tr><tr><td valign="bottom">pcDNA5-FRT/TO-YFP- <break/>FKBP*12(F36V/L106P)-GPI</td><td valign="bottom">mammalian cell expression</td><td valign="bottom">FKBP*12 containing <break/>destabilizing mutations, <break/>followed by YFP and GPI- <break/>anchor signal. For stable- <break/>inducible expression.</td><td valign="bottom">pcDNA5/FRT/TO</td><td valign="bottom">CMV Tet-on</td></tr><tr><td valign="bottom">pET15b-HisFKBP*12 F36V</td><td valign="bottom">bacterial expression</td><td valign="bottom">Recombinant FKBP*12 <break/>to bind excess Shield1 <break/>during washout.</td><td colspan="2" valign="bottom">Created by T. Wandless (Addgene Plasmid #73180)</td></tr><tr><td valign="bottom">FusionRed-Dynamin S45N</td><td valign="bottom">mammalian cell expression</td><td valign="bottom">Dominant-negative <break/>dynamin mutant</td><td colspan="2" valign="bottom">Gift from H. McMahon's lab (MRC-LMB, Cambridge)</td></tr><tr><td valign="bottom">pcDNA3-3xmyc-TMED2</td><td valign="bottom">mammalian cell expression</td><td valign="bottom">Human TMED2 with 3xmyc <break/>tag following <break/>signal sequence.</td><td valign="bottom">pcDNA3.1 (+) zeo</td><td valign="bottom">CMV</td></tr><tr><td valign="bottom">nanobody APEX2</td><td valign="bottom">bacterial expression</td><td valign="bottom">nanobody-APEX2-FLAG <break/>for bacterial expression</td><td valign="bottom">pRSET</td><td valign="bottom">T7</td></tr><tr><td valign="bottom">mGFP1-N1</td><td valign="bottom">mammalian cell expression</td><td valign="bottom">cytosolic GFP</td><td valign="bottom">pmGFP</td><td valign="bottom"/></tr><tr><td valign="bottom">pcDNA5-FRT/TO-EGFP-PrP*</td><td valign="bottom">mammalian cell expression</td><td valign="bottom">C179A mutant of hamster <break/>PrP with bovine prolactin <break/>signal sequence; EGFP <break/>@ unique Bsu36I site <break/>downstream of signal <break/>sequence.</td><td valign="bottom">pcDNA5/FRT/TO</td><td valign="bottom">CMV Tet-on</td></tr><tr><td valign="bottom">pcDNA5-FRT/TO-EGFP-PrP</td><td valign="bottom">mammalian cell expression</td><td valign="bottom">Wild-type human PrP, <break/>with EGFP @ unique Bsu36I <break/>site downstream of signal <break/>sequence.</td><td valign="bottom">pcDNA5/FRT/TO</td><td valign="bottom">CMV Tet-on</td></tr></tbody></table></table-wrap>